GlaxoSmithkline Consumer Healthcare inches up on reporting 37% rise in Q2 net profit

09 Nov 2015 Evaluate

GlaxoSmithkline Consumer Healthcare is currently trading at Rs. 5918.70, up by 17.05 points or 0.29% from its previous closing of Rs. 5901.65 on the BSE.

The scrip opened at Rs. 5885.00 and has touched a high and low of Rs. 5945.00 and Rs. 5877.85 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6564.05 on 15-Apr-2015 and a 52 week low of Rs. 5425.10 on 16-Dec-2014.

Last one week high and low of the scrip stood at Rs. 6023.45 and Rs. 5825.15 respectively. The current market cap of the company is Rs. 24,891.00 crore.

The promoters holding in the company stood at 72.46% while Institutions and Non-Institutions held 12.57% and 14.98% respectively.

The company has reported 36.86% rise in its net profit at Rs 219.37 crore for the quarter ended September 30, 2015 as compared to Rs 160.29 crore for the same quarter in the previous year. The company’s total income has increased by 0.65% to Rs 1183.05 crore for the quarter under review from Rs 1175.46 crore for the corresponding quarter of the previous year.

GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.


Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 2248.15
Britannia Inds 4844.70
Varun Beverages 616.65
Marico 599.20
Hatsun Agro Product 1051.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.